Top Markets
Coin of the day
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Rangering i aksjer #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Aksjekurs
$7.15
Markedsverdi
$313.60M
Endring (1 dag)
-2.12%
Endring (1 år)
-84.14%
Land
DE
Handel Anbio Biotechnology Class A Ordinary Shares (NNNN)

Kategori

Historikk for aksjesplitt for Anbio Biotechnology Class A Ordinary Shares (NNNN)
Aksjen Anbio Biotechnology Class A Ordinary Shares (symbol: NNNN) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Sep 01, 2026.
Én NNNN-aksje kjøpt før Sep 01, 2026 tilsvarer i dag 0 NNNN-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
3 x4
US
3 x20
FR
0 -
JP
6 x20
US
0 -
CH